UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 206

Sortiert nach

Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes

Frontiers in endocrinology (Lausanne), 2019-02, Vol.10, p.80-80

Deacon, Carolyn F

2019

Link zum Volltext

Verfügbarkeit prüfen

A review of dipeptidyl peptidase‐4 inhibitors. Hot topics from randomized controlled trials

Diabetes, obesity & metabolism, 2018-02, Vol.20 (S1), p.34-46

Deacon, Carolyn F.

2018

Link zum Volltext

Verfügbarkeit prüfen

Metabolism of GIP and the contribution of GIP to the glucose-lowering properties of DPP-4 inhibitors

Peptides (New York, N.Y. : 1980), 2020-03, Vol.125, p.170196-170196, Article 170196

Deacon, Carolyn F

2020

Link zum Volltext

Verfügbarkeit prüfen

Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus

Nature reviews. Endocrinology, 2020-11, Vol.16 (11), p.642-653

Deacon, Carolyn F

2020

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Strategies Based on Glucagon-Like Peptide 1

Diabetes (New York, N.Y.), 2004-09, Vol.53 (9), p.2181-2189

DEACON, Carolyn F

2004

Link zum Volltext

Verfügbarkeit prüfen

Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety

Expert opinion on pharmacotherapy, 2013-10, Vol.14 (15), p.2047-2058

2013

Link zum Volltext

Verfügbarkeit prüfen

A Protein Preload Enhances the Glucose-Lowering Efficacy of Vildagliptin in Type 2 Diabetes

Diabetes care, 2016-04, Vol.39 (4), p.511-517

2016

Link zum Volltext

Verfügbarkeit prüfen

The Glucagonostatic and Insulinotropic Effects of Glucagon-Like Peptide 1 Contribute Equally to Its Glucose-Lowering Action

Diabetes (New York, N.Y.), 2010-07, Vol.59 (7), p.1765-1770

2010

Link zum Volltext

Verfügbarkeit prüfen

Effects of Sitagliptin and Metformin Treatment on Incretin Hormone and Insulin Secretory Responses to Oral and Isoglycemic Intravenous Glucose

Diabetes (New York, N.Y.), 2014-02, Vol.63 (2), p.663-674

2014

Link zum Volltext

Verfügbarkeit prüfen

Bile acids are important direct and indirect regulators of the secretion of appetite- and metabolism-regulating hormones from the gut and pancreas

Molecular metabolism (Germany), 2018-05, Vol.11, p.84-95

2018

Link zum Volltext

Verfügbarkeit prüfen

Activation of GLP-1 receptors on vascular smooth muscle cells reduces the autoregulatory response in afferent arterioles and increases renal blood flow

American journal of physiology. Renal physiology, 2015-04, Vol.308 (8), p.F867-F877

2015

Link zum Volltext

Verfügbarkeit prüfen

What do we know about the secretion and degradation of incretin hormones?

Regulatory Peptides, 2005-06, Vol.128 (2), p.117-124

Deacon, Carolyn F.

2005

Link zum Volltext

Verfügbarkeit prüfen

Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans

European journal of endocrinology, 2014-04, Vol.170 (4), p.529

2014

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum: Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes

Frontiers in endocrinology (Lausanne), 2019-05, Vol.10, p.275-275

Deacon, Carolyn F

2019

Link zum Volltext

Verfügbarkeit prüfen

A carbohydrate-reduced high-protein diet acutely decreases postprandial and diurnal glucose excursions in type 2 diabetes patients

British journal of nutrition, 2018-04, Vol.119 (8), p.910-917

2018

Link zum Volltext

Verfügbarkeit prüfen

What Is an L-Cell and How Do We Study the Secretory Mechanisms of the L-Cell?

Frontiers in endocrinology (Lausanne), 2021-06, Vol.12, p.694284-694284

2021

Link zum Volltext

Verfügbarkeit prüfen

Peptide degradation and the role of DPP-4 inhibitors in the treatment of type 2 diabetes

Peptides (New York, N.Y. : 1980), 2018-02, Vol.100, p.150-157

Deacon, Carolyn F.

2018

Link zum Volltext

Verfügbarkeit prüfen

Physiology of incretins in health and disease

The review of diabetic studies, 2011, Vol.8 (3), p.293-306

2011

Link zum Volltext

Verfügbarkeit prüfen

Measurement of the incretin hormones: glucagon-like peptide-1 and glucose-dependent insulinotropic peptide

Journal of diabetes and its complications, 2015-04, Vol.29 (3), p.445-450

2015

Link zum Volltext

Verfügbarkeit prüfen

Impact of dipeptidyl peptidase-4 inhibitors on glucose-dependent insulinotropic polypeptide in type 2 diabetes mellitus: a systematic review and meta-analysis

Frontiers in endocrinology (Lausanne), 2023-08, Vol.14, p.1203187-1203187

2023

Link zum Volltext

Verfügbarkeit prüfen

Cephalic phase secretion of insulin and other enteropancreatic hormones in humans

American journal of physiology: Gastrointestinal and liver physiology, 2016-01, Vol.310 (1), p.G43-G51

2016

Link zum Volltext

Verfügbarkeit prüfen

Do sodium‐glucose co‐transporter‐2 inhibitors increase plasma glucagon by direct actions on the alpha cell? And does the increase matter for the associated increase in endogenous glucose production?

Diabetes, obesity & metabolism, 2021-09, Vol.23 (9), p.2009-2019

2021

Link zum Volltext

Verfügbarkeit prüfen

Secretion and Dipeptidyl Peptidase-4-Mediated Metabolism of Incretin Hormones after a Mixed Meal or Glucose Ingestion in Obese Compared to Lean, Nondiabetic Men

The journal of clinical endocrinology and metabolism, 2010-02, Vol.95 (2), p.872-878

2010

Link zum Volltext

Verfügbarkeit prüfen

Incretin and islet hormonal responses to fat and protein ingestion in healthy men

American journal of physiology: endocrinology and metabolism, 2008-10, Vol.295 (4), p.E779-E784

2008

Link zum Volltext

Verfügbarkeit prüfen

Incretin-based treatment of type 2 diabetes: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors

Diabetes, obesity & metabolism, 2007-09, Vol.9 (s1), p.23-31

Deacon, Carolyn F

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 206

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(181)
Mit Volltextzugriff
(188)

Publikationsform

Sprache

Englisch
(206)
Japanisch
(55)

Erscheinungsjahr

n.n

Thema

Science & Technology
(157)
Life Sciences & Biomedicine
(156)
Humans
(116)
Endocrinology & Metabolism
(110)
Male
(78)
Biological And Medical Sciences
(64)
Female
(57)
Glucagon
(53)
Animals
(52)
Diabetes
(47)
Middle Aged
(47)
Medical Sciences
(44)
Diabetes Mellitus, Type 2 - Drug Therapy
(43)
Peptides
(43)
Adult
(41)
Blood Glucose - Metabolism
(40)
Glucose
(40)
Endocrinopathies
(38)
Insulin
(38)
Type 2 Diabetes
(38)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes

A review of dipeptidyl peptidase‐4 inhibitors. Hot topics from randomized controlled trials

Metabolism of GIP and the contribution of GIP to the glucose-lowering properties of DPP-4 inhibitors

Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus

Therapeutic Strategies Based on Glucagon-Like Peptide 1

Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety

A Protein Preload Enhances the Glucose-Lowering Efficacy of Vildagliptin in Type 2 Diabetes

The Glucagonostatic and Insulinotropic Effects of Glucagon-Like Peptide 1 Contribute Equally to Its Glucose-Lowering Action

Effects of Sitagliptin and Metformin Treatment on Incretin Hormone and Insulin Secretory Responses to Oral and Isoglycemic Intravenous Glucose

Bile acids are important direct and indirect regulators of the secretion of appetite- and metabolism-regulating hormones from the gut and pancreas

Activation of GLP-1 receptors on vascular smooth muscle cells reduces the autoregulatory response in afferent arterioles and increases renal blood flow

What do we know about the secretion and degradation of incretin hormones?

Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans

Corrigendum: Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes

A carbohydrate-reduced high-protein diet acutely decreases postprandial and diurnal glucose excursions in type 2 diabetes patients

What Is an L-Cell and How Do We Study the Secretory Mechanisms of the L-Cell?

Peptide degradation and the role of DPP-4 inhibitors in the treatment of type 2 diabetes

Physiology of incretins in health and disease

Measurement of the incretin hormones: glucagon-like peptide-1 and glucose-dependent insulinotropic peptide

Impact of dipeptidyl peptidase-4 inhibitors on glucose-dependent insulinotropic polypeptide in type 2 diabetes mellitus: a systematic review and meta-analysis

Cephalic phase secretion of insulin and other enteropancreatic hormones in humans

Do sodium‐glucose co‐transporter‐2 inhibitors increase plasma glucagon by direct actions on the alpha cell? And does the increase matter for the associated increase in endogenous glucose production?

Secretion and Dipeptidyl Peptidase-4-Mediated Metabolism of Incretin Hormones after a Mixed Meal or Glucose Ingestion in Obese Compared to Lean, Nondiabetic Men

Incretin and islet hormonal responses to fat and protein ingestion in healthy men

Incretin-based treatment of type 2 diabetes: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors

Suchergebnisse filtern